
Opinion|Videos|June 24, 2024
Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer
A panel of experts on prostate cancer discuss the role for fusion-guided biopsies in active surveillance for patients with prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Is there a role for fusion-guided biopsies in active surveillance for patients with prostate cancer?
- Historically what has been the standard approach for active surveillance? Which patients? How often do you monitor?
- How can fusion-guided biopsies improve surveillance strategies and inform treatment and management decisions to improve outcomes?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Annual ACS NCDB report details national trends in prostate cancer care
2
Treatment Selection in Advanced Prostate Cancer
3
FDA provides guidance on development pathway for testosterone therapy for women
4
Strategic Use of ADT in mCSPC From Selection to Escalation
5








